BrilliA (BRIA) vs Ping An Biomedical (PASW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Ping An Biomedical (PASW) has outperformed BrilliA (BRIA) over the past year, gaining 113.2% versus a loss of 20.1%. BrilliA is the larger company by market cap ($35.0 million vs $3.2 million), about 11.0 times the size. BrilliA converts more of its revenue into profit, with a net margin of 4.4% versus -37.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BRIA | PASW |
|---|---|---|
| Share price | $1.40 | $1.13 |
| Market cap | $34.98M | $3.19M |
| 1-day change | -5.47% | -10.32% |
| YTD return | -12.01% | +125.10% |
| 1-year return | -20.06% | +113.21% |
| Forward P/E | 8.74 | — |
| EPS (TTM) | $-0.01 | $-2.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $64.39M | $4.80M |
| Revenue growth (YoY) | +15.06% | — |
| Net income (latest FY) | $2.81M | $-1.80M |
| Gross margin | 16.20% | 2.78% |
| Operating margin | — | -43.05% |
| Net margin | 4.37% | -37.57% |
| 52-week high | $2.30 | $28.56 |
| 52-week low | $1.07 | $1.07 |
| Distance from 52-week high | -39.17% | -96.04% |
| Analyst consensus | none | — |
| Avg. price target upside | +96.57% | — |
| Average volume | 3.78K | 188.54K |
| Shares outstanding | 25.00M | 2.82M |
| Employees | 239 | 7 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Apparel | Apparel |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BrilliA is about 11.0 times larger than Ping An Biomedical by market value ($34.98M vs $3.19M).
- PASW has outperformed BRIA by 133.3 percentage points over the past year.
- BrilliA is more profitable, keeping 4.4 cents of every revenue dollar as net income versus -37.6 cents for Ping An Biomedical.
About BrilliA
BRIA stock →BrilliA Inc, through its subsidiaries, engages in the sales and marketing of lingerie products in North America, the European Union, the Asia Pacific, Latin America, the Middle East, and internationally. The company's products include active, sleep, and baby wear; period panties; panties; brassiere; bodysuits; dresses; swimsuits; tops; and other products under DIANA, Vanity Fair, Hanes, Wonderbra, Playtex, Bali, Maidenform, Jockey, Lands' End, fleur du mal, Kiki de Montparnasse, and Bra n Things brands.
Consumer Discretionary · Apparel · 239 employees
About Ping An Biomedical
PASW stock →Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management.
Consumer Discretionary · Apparel · 7 employees
BRIA vs PASW FAQ
Which is bigger, BrilliA or Ping An Biomedical?
BrilliA (BRIA) is larger, with a market capitalization of $34.98M compared with $3.19M for Ping An Biomedical (PASW).
Which stock has performed better over the past year, BRIA or PASW?
PASW returned +113.21% over the past 12 months, compared with -20.06% for BRIA (price return, excluding dividends). Past performance does not predict future results.
Are BrilliA and Ping An Biomedical in the same industry?
Yes. Both are classified in the Apparel industry within the Consumer Discretionary sector.